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A series of l-aryllcyclohexyl-3, 3-diphenyl-l'-
(diphenylacetyl)-2-oxospiro[ azetidin-4,3 '-indolin-2'-ones]
4a-h has been synthesized by the reaction of diphen-
ylketene, generated in situ from the thermal decomposi-
tion of 2-diazo-l,2-diphenylethanone 1 with 3-N-
aryllcyclohexyliminoindolin-2-ones 2a-h in 2: 1 molar
ratio. These spiroazetidinones, also obtainable by an
equirnolar reaction of diphenyketene with 1-
diphenylacetyl derivatives 3 of the latter, have been
characterized on the' basis of elemental and· spectral (IR
1 13 'Hand C NMR and mass) analyses and screened for
their anticonvulsant activity. Two compounds 4e and 4h
exhibit highly significant activity against MES.
Isatin derivatives constitute an important class of
heterocycles with a broad range of biological
activities I, such as anticonvulsant, anti-
inflammatory and CNS depressant activities which
prompted us to investigate the reaction of its 3-N-
substituted imines with 2-diazo-1 2-
diphenylethanone 1, a precursor of diphenylkete~e.
Ketenes are known to afford azetidinones2
lactones and amides3 by reactions with th~
substrates containing C=N, C=O and N-H groups,
respectively. However, these reactions often
depend on structural environment of the molecule
e.g., reaction of diphenylketene with N~
benzhydrylidene-N'-phenylurea 4 fluorinone-N-
5 'benzoylhydrazone and benzophenone-N-
diphenylacetyl hydrazone" occurred at C=N group
leading to the formation of azetidinones in first
two cases and diazopropanones were obtained in
the third case. The reaction of phenoxyketene with
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benzophenone-N-phenylhydrazones has been
reported to occur at N-H group ofthe latter'.
We have recently reported an equimolar
reaction of 1. with 3-N-substituted isatinimines 2
leading to an exclusive formation of the
corresponding N-diphenylacetyl derivatives 38. In
continuation to this study, we wish to report the
synthesis of new l-aryllcyclohexyl-3,3-diphenyl-
1'-(diphenylacetyl)-2-oxospiro[ azetidin-4,3 '-indolin-
2'-one] 4a-h from the reaction of diphenylketene,
obtained by thermal decomposition of 1 with 3-N-
aryllcyclohexyliminoindolin-2-ones 2a-h in 2: 1
molar ratio (Scheme I). The spiroazetidinones 4a-
h, also obtainable from an equimolar reaction of 1
with 3a-h, have been screened for their activity
against MES and Chemoshock induced seizures.
Only a few spiroazetidinones are known in the
literature which have been obtained from the
reactions of (i) acid chlorides with anils''; (ii)
isocyanates with olefins'"; and dipenylketene with
hydrazones and ketoimines II.
The spiroazetidinones 4a-h obtained above were
crystallized from ethanol in good yields and their
structures were characterized on the basis of their
physical (Table I) and spectral (lR, IH and 13C
NMR and mass) data (Table II). The IR spectra
exhibited· three strong absorption bands at 1765±5
(C=O,y-lactam), 1747±3 (C=O, 13-lactam) and
1716· (COCH) em -I. The 13C NMR spectra showed
three carbonyl carbons in range of 175.10-172.70
(13-lactam carbonyl carbon) 172.89-172.52 (sd,
J2C-H=7.27 Hz, COCH) and 167.95-165.41 ppm
(y-Iactam carbonyl carbon). It showed two signals
at about 878.00 and 72.00 ppm which were
assignable to C-3', 4 and C-3 carbons, respectively.
The methine carbon appearaed as a doublet at
857.00 ppm. The proton at this carbon appeared as
a singlet at 86.31 ppm in the IH NMR spectra. The
mass spectra showed the respective M+ peaks and
a fragment at 194 (Ph2C=C-O) as a base peak. The
other main fragments correspond to M+-
Ph2C=C=O, 4-Ph2COCH and Ph2CH.
The reaction sequence for the formation of 4a-h
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Table I-Physical data of spiroazetidinones 4a-h
Compd R Yield m.p. Mol. formula Found (%) (Calc.)
(%) °c C H N
4a Phenyl 66 142-43 C42H30N203 82.73 4.93 4.60
(82.62 4.91 4.59)
4b 4-Methylphenyl 69 188-89 C43H32Nz03 82.45 5.26 4.35
(82.69 5.12 4.48)
4c 4-Methoxyphenyl 73 198 C43H32N204 80.69 5.09 4.33
(80.62 5.00 4.37)
4d 4-Ethoxyphenyl 78 186-87 C44H34Nz04 80.70 5.21 .1.25
(80.73 5.19 4.28)
4e 4-Chlorophenyl 59 208-9 C42H29Nz03Cl 78.15 4.62 4.37
(78.26 4.50 4.34)
4f 4-Nitrophenyl 61 233-34 C42H29N30S 76.73 4-.45 6.40
(76.94 4.42 6.41)
4g Cyclohexyl 75 184-85 C42H36N203 82.02 6.10 4.46
(81.81 5.84 4.54)
4h I-Naphthyl 77 217-18 C46H32N203 83.75 4.86 4.16
(83.63 4.84 4.24)
is shown in Scheme 1. Thermal decomposition of 1
with extrusion of N2 yields diphenylketene as a
result of wolff-rearrangement of the resulting
benzoylphenylcarbene. The diphenylketene reacts
preferentially with amido nitrogen of 2 giving rise
to its corresponding N-diphenylacetyl derivative 3.
An imino nitrogen in the latter reacts with a second
molecule of diphenylketene to give a possible
zwitterionic intermediate which finally cyc1izes to
furnish spiroazetidinones 4a-h. The formation of
similar zwitterions have been proposed earlier in
h hesi f idi 411t e synt srs 0 azeti mones " .
Anticonvulsant activity. The screening of
compounds 3a-h by maximal electroshock
(
12 13MES) . and chemoshock methods showed a
profile of anticonvulsant activity. The compounds
4h with naphthyl substituent showed 100%
protection at the dose level of 200 mg/kg, i.p.
which was similar to the activity of standard drug
phenobarbitone. However, its LDso value of 150
mg/kg was less in comparison with the standard
drug (270 mg/kg).
p-Chlorosubstituted spiroazetidinone 4e
protected 80% animals while other compounds of
the series showed 30-60% protection. All the
compounds of the series, however, responded
insignificantly (0-30%) to picrotoxin and
strychnine induced seizures.
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Table II-Spectral Data of Spiroazetidinones 4a-h
Compd 'H NMR BC NMR
(CDCI3, Sppm) (CDCI3, Sppm)
4a 8.45(d,.l=8.24 Hz,1 H, arom), 173.31, 172.85(sd,.l=7.27 Hz), 165.67, 140.19,
7.23(m,21 H, arom), 6.98(m, 3 H, 137.07,137.99,137.34,136.60,136.01,131.09,
arom), 6.83(td,.l=6.60, 0.99 Hz,1 I LO.3, 129.21, 129.09, 128.67, 128.60,
H, arom), 6.31(s,1 H, CH), 128.40128.05,127.95, 127.64, 127.45,
7.48(m,2 H, arom), 127.37126.52,126.32, 125.Q1, 124.86, 122.20,
6.28(dd,J=6.60, 0.99 Hz,1 H, 122.14,117.34,116.99,78.22,71.84,
arom) 56.94(dm, CH)
4b 8.44(d,J=8.24 Hz, 1 H, arom),
7.26(m, 25 H, arom), 6.82(td, IH,
arom), 6.32(s, 1H, CH), 628(dd, 1
H, arom), 2.24(s, 3 H, CH3)
4c 8.43(d,J=8.24 Hz, 1 H, arom),
7.28(m,21 H, arom), 6.92, (dd,2
H, arom), 6.84 (t,1 H, arom),
6.63(dd,2 H, arom), 6.31(s,1 H,
CH), 6.28 (d,J=7.22 Hz, 1 H,
arom), 3.69(s,3 H, OMe)
8.44(d,J=8.24 Hz, 1 H, arom),
7.27(m, 21 H, arom), 6.92(dd, 2
H, arom), 6.88(td, 1 H, arom),
6.60(dd, 2 H, arom), 6.32(s, 1 H,
CH), 6.26(dd,1 H, arom) 3.90(q,2
H, OCH2), 1.31(t,3 H, CH3)
8.44(d,.l=8.24 Hz,1 H, arom),
7. 15(m,26 H, arom), 6.34(s, I H,
CH), 6.31(dd,1 H, arom)
4d
4e
4f 8.47(d,J=7.92 Hz,1 H, arom),
7.95(dd,2 H, arom), 7.27(m, 23 H,
arom), 6.82(td, 1 H, arom), 6.25(s,
1 H, CH), 6.23(dd,1 H, arom)
8.29(d,.l=7.92 Hz,1 H, arom),
7.19(m,21 H, arom), 6.84(td, 1 H,
arom), 6.32(s,1 H, CH), 6.23(dd,1
H, arom), 3.20(m,1 H, N-CH),
1.45(m, 10 H, 5 CH2)
4g
4h 8.24(d,J=8.24 Hz,1 H, arom),
8.09(d,J=8,90 Hz, 1 H, arom),
7.70(d,J=7.26 Hz,1 H, arom),
7.59(d,J=8.25 Hz,1 H, arom),
7.42(m,4 H, arom), 7.16(m,20 H,
6.90(t,./=8.00 Hz,1 H, arom),
6.67(m,1 H, arom), 6.30(dd, 1 H,
arom), 6.28(s,1 H, CH)





117.45, 116.95, 78.18, 71.88, 56.85,
20.85
173.51, 172.82(sd,J=7.93 Hz), 165.42, 156.77,
140.31,138.10,138.05,137.48,136.79,131.04,
129.20,129.11,128.66, 128.58(two C), 128.37,
128.31128.07,127.88,127.57,127.43,127.31,
126.54, 126.32, 124.96, 122.31, 119.45, 116.93,
114.42,78.33,72.18,56.91,55.34 (q, OMe)



















127.35, 127.29, 126.56, 126.44, 124.63, 123.60,
116.7G, 77.70, 71.79, 57.26(d), 54. 17(dm), 31.83,
30.36,25,13, 25.09, 25,04, 24.86
174.35,172.79,167.17,140.98,138.45,138.17,
137.87,137.46,134,24,131.06,130.73,129.60,
129.30, 129.08, 128.69, 128.63, 128.59, 128.50,
129.31,128.17,128.12,127.96,127.54,127.44,





















393, 296, 256, 228,
194( 100), 166(30), I I I, 78









272( 100), 243, 220,
194(40),165(45),127(15),
82
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Experimental Section
Melting points have been determined on a Buchi
apparatus and are uncorrected. The IR spectra were
recorded in KBr on a Perkin- Elmer 720
spectrophotometer; IH and 13C NMR spectra in
CDCl3 on Geol FX 270 MHz and 67.8 MHz
spectrometers, respectively using TMS as an
internal standard, and mass spectra on Hitachi
Perkin-Elmer model RMU-6E spectrometer at
70 ev.
2-Diazo-1,2-diphenylethanone 1 was prepared
by well-known method and ketoimines 2a-h were
prepared by the literature procedure".
Synthesis of 4a-h. General procedure. A
mixture of 1 (2.22 g, 10 mmoles) and 2a-h (5
mmoles) was heated to reflux in dry benzene
(80 mL) for 6 hr under a stream of nitrogen. The
solvent was removed on rotatory evaporator and
the residue crystallised from ethanol to give
spiroazetidinones 4a-h.
Similarly the reaction of 1 (1.11 g, 5 mmoles)
with an equimolar amount of 3a-h as described
above gave 4a-h.
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